Early identification will be highly significant, given the growing prevalence of MASLD, allowing preventive measures to reduce fibrosis progression and potential HCC development[ 248 ].
← all excerpts
Artificial intelligence and digital transformation of gastroenterology and hepatology: A critical review of clinical applications and future challenges.
1
—
—